First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
Resource Type
Article
Authors
Jongsma, Maria M. E. ; Aardoom, Martine A. ; Cozijnsen, Martinus A. ; van Pieterson, Merel ; de Meij, Tim ; Groeneweg, Michael ; Norbruis, Obbe F. ; Wolters, Victorien M. ; van Wering, Herbert M. ; Hojsak, Iva ; Kolho, Kaija-Leena ; Hummel, Thalia ; Stapelbroek, Janneke ; van der Feen, Cathelijne ; van Rheenen, Patrick F. ; van Wijk, Michiel P. ; Teklenburg-Roord, Sarah T. A. ; Schreurs, Marco W. J. ; Rizopoulos, Dimitris ; Doukas, Michail
Source
Gut; Jan2022, Vol. 71 Issue 1, p34-42, 9p
Subject
CROHN'S disease DIAGNOSIS SHIGELLOSIS MEDICAL ethics DISEASE remission INFLIXIMAB MEDICAL personnel
Language
ISSN
00175749